GlaxoSmithKline plc (LON:GSK) declared a dividend on Wednesday, July 29th, Upcoming.Co.Uk reports. Shareholders of record on Thursday, August 13th will be given a dividend of GBX 19 ($0.23) per share on Thursday, October 8th. This represents a yield of 1.22%. The ex-dividend date of this dividend is Thursday, August 13th. The official announcement can be seen at this link.
Shares of GSK stock traded down GBX 50.80 ($0.63) during trading hours on Thursday, hitting GBX 1,553.80 ($19.12). The company’s stock had a trading volume of 8,367,957 shares, compared to its average volume of 9,120,000. The company has a current ratio of 0.87, a quick ratio of 0.54 and a debt-to-equity ratio of 159.26. The business has a fifty day moving average of GBX 1,626.70 and a 200-day moving average of GBX 1,638.38. GlaxoSmithKline has a twelve month low of GBX 16.27 ($0.20) and a twelve month high of GBX 1,857 ($22.85). The stock has a market cap of $77.96 billion and a price-to-earnings ratio of 14.52.
GlaxoSmithKline (LON:GSK) last posted its earnings results on Wednesday, April 29th. The company reported GBX 37.70 ($0.46) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of GBX 31.10 ($0.38) by GBX 6.60 ($0.08). On average, equities analysts expect that GlaxoSmithKline will post 11385.0001492 EPS for the current fiscal year.
GlaxoSmithKline Company Profile
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare.
Featured Story: Different Options Trading Strategies
Receive News & Ratings for GlaxoSmithKline Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline and related companies with MarketBeat.com's FREE daily email newsletter.